Infinity Bio

Infinity Bio is a technology company that provides detailed insights into the immune system using its proprietary core technology that comprehensively measures the antibody reactome, revealing the targets of individual immune responses against all known human viruses, human proteins (autoimmunity), and allergen proteins. Infinity's assay, MIPSA, was developed at Johns Hopkins University in Ben Larman's Lab of Precision Immunology. It builds off decades of work in the fields of genomics, proteomics, immunology, and bioinformatics. Infinity Bio's assay was engineered to enable best-in-class quality, turnaround times and cost.